Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update

Go back to Roth Capital Remains Positive on Keryx (KERX) Following Q3 Results, Update

Form 8-K KERYX BIOPHARMACEUTICALS For: Nov 06

November 6, 2014 7:32 AM EST

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

... More